The joumal uses Crossref ited-by service counts times cited of published aricles. Citedby allows Crossref members to find out who is citing their conten. This is the Citing Article List of “Receptor tyrosine kinase-like orphan receptor 1 inhibitor strictinin exhibits anti-cancer properties against highly aggressive androgen-independent prostate cancer”.
|
No. |
Publication Date |
Citing Article |
|
1 |
2024 |
Yifan Hou, Zhenhua Zhao, Pan Li, Yujia Cao, Yi Zhang, Changsheng Guo, Xiaobo Nie, Junqing Hou. Combination therapies with Wnt signaling inhibition: A better choice for prostate cancer treatment, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 2024; 1879: 189186189186. https://doi.org/10.1016/j.bbcan.2024.189186 |
|
2 |
2025 |
John T. Phoenix, Audris Budreika, Devin A. Schmeck, Raymond J. Kostlan, Marina G. Ferrari, Kristen S. Young, Charles S. Rogers, Carleen D. Deegan, Marcus W. Bienko, Hannah E. Bergom, Ella Boytim, Ryan M. Brown, Julia A. Walewicz, Shreya K. Bhagi, Leigh Ellis, Emmanuel S. Antonarakis, Justin M. Drake, Pushpinder S. Bawa, Jordan E. Vellky, Anthony Williams, Natalie M. Rezine, Jonathan P. Rennhack, Sean W. Fanning, Justin H. Hwang, Russell Z. Szmulewitz, Donald J. Vander Griend, Steven Kregel. 2025; https://doi.org/10.1101/2025.07.18.664790 |
|
3 |
2024 |
Vignesh Sivaganesh, Tram M. Ta, Bela Peethambaran. Pentagalloyl Glucose (PGG) Exhibits Anti-Cancer Activity against Aggressive Prostate Cancer by Modulating the ROR1 Mediated AKT-GSK3β Pathway, International Journal of Molecular Sciences. 2024; 25: 7003. https://doi.org/10.3390/ijms25137003 |
|
4 |
2024 |
Lin Li, Weixue Huang, Xiaomei Ren, Zhen Wang, Ke Ding, Linxiang Zhao, Jinwei Zhang. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies, Science China Life Sciences. 2024; 67: 2603. https://doi.org/10.1007/s11427-024-2685-9 |